INHIBITION OF DIFFERENT STAGES OF BIOFILM OF PSEUDOMONAS AERUGINOSA PA01 BY ISOLATED BACTERIOPHAGE P2
Abstract
Â
Biofilm mediated protection of pathogens from environmental stresses are recognized as one of the major threat worldwide, which encourage the
researcher to search for other alternative approach. Bacteriophage therapy is one such effective and controlled strategy that undertakes the utilization
of tailored phage mediated biofilm inhibition. Hence, in this study, P2 phage, specific to Pseudomonas aeruginosa PA01 was isolated and its potential
to inhibit biofilm formation was studied. Important findings are summarized in the manuscript.
Keywords: Pseudomonas aeruginosa, Biofilm, Bacteriophage and Transmission electron microscopy, Antibiotic resistance.
Downloads
References
Palleroni NJ.. Pseudomonadaceae Kreig R, Holt J G (Eds.). In Bergey’s manual of systematic bacteriology, Baltimore, MD: Williams & Wilkins Co. (1984) pp. 141–199.
Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey M J et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 20004; 06:959–964
Costerone JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318–1322.
Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discovery 2003; 2:114–122.
Donlan R, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15:167–193.
Mah TF, O’Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trend Microbiol 2001; 9:34–39.
O’Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol. 2000; 54:49–79.
Foley I, Gilbert P. Antibiotic resistance of biofilms. Biofouling 1996; 10:331–346.
Costerton JW. Introduction to biofilm. Int J Antimicrob Agen 1999; 11: 217-221
Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole, GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003; 426:306-310.
Theil K. Old dogma, new tricks—21st century phage therapy. Nat Biotechnol 2004; 22:31–36.
Skurnik M, Pajunen M, Kiljunen S. Biotechnological challenges of phage therapy, Biotechnol Lett 2007; 29:995–1003.
Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: The unseen majority. Proc Natl Acad Sci USA, 1998; 95:6578–6583.
Rohwer F, Edwards R. The phage proteomic tree: A genome-based taxonomy for phage. J Bacteriol 2002; 184:4529–4535.
Hughes KA, Sutherland IW, Clark J, Jones MV. Bacteriophage and associated polysaccharide depolymerases—novel tools for study of bacterial biofilms. J Appl Microbiol 1998; 85:583–590.
Cerveny KE, DePaola A, Duckworth DH, Gulig PA. Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron- dextran -treated mice. Infect Immun 2002; 70 (11):6251-6262.
Sambrook J, Fritsch EF, Maniatis T.. Molecular cloning: a laboratory manual, 2nd ed, 1989; Cold Spring Habor laboratory Press, Cold Spring Harbor, N.Y.
O'Toole and Kolter. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 1998; 28(3):449-61
Goodridge L, Gallacci A, Griffiths MW. Morphological, host range and genetic characterization of two coliphages. Appl Environ Microbiol 2003;69(9):5364-5371.
Soboh F, Khoury AE, Zamboni AC, Davidson D, Mittelman MW. Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms. Antimicrob Agen Chemother 1995; 39:1281-1286.
Ackermann HW. Phage classification and characterization, Methods Mol Biol 2009; 50:1127-40.
Weitao T. Multicellularity of a unicellular organism in response to DNA replication stress. Res Microbiol. 2009; 160:87-88.
Nakai T, Park SC. Bacteriophage therapy of infectious diseases in aquaculture. Res Microbiol 2002; 15:313-18.
Loc CC, Atterbury RJ, Shibiny EA, Connerton PL, Dillon E, Scott A, Connerton IF. Bacteriophage therapy to reduce Campylobacter jejuni colonization of Broiler Chickens. Appl Environ Microbiol, 2005; 71:6554-6563.
Wagenaar JA, Bergen MAPV, Mueller MA, Wassenaar TM, Carlton RM. Phage therapy reduces Campylobacter jejuni colonization in broilers. Vet Microbiol. 2005; 109:275-283
McVay CS, Velasquez M, Fralick JA. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob Agen Chemother. 2007; 51:1934-1938.
Weber DB, Mulczyk M, Gorski A. Bacteriophage therapy for infections in cancer patients. Clin Appl Immunol Rev 2001; 1:131-134.
Weber DB, Mulczyk M, Gorski A. Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transplant Proceed. 2003; 35:1385-1386.
Pires D, Sillankorva S, Faustino A, Azeredo J. Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 bioï¬lms. J Res Microbiol 2011; 162:798-806
Balakshina VV, Kulakov LA, Boronin AM. Dynamics of the Interaction of bacteriophage Phi- Mf81 with Its Host, Pseudomonas aeruginosa. Microbiology 1992; 61:741–744.
Knezevic OD, Curcin S, Petrusic M, Aleksic V, Kostanjsek R, Petrovic O. Phages of Pseudomonas aeruginosa: response to environmental factors and in vitro ability to inhibit bacterial growth and biofilm formation. A Microbiol. 2011; 111:245–254.
Hosseinidoust Z. 2012. An investigation of bacteriophage-bacteria interactions: development of phage resistance and associated variations in virulence and biofilm formation, PhD thesis. McGill University.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.